How to tackle congestion in acute heart failure

키워드

참고문헌 (75)

1. Gheorghiade M, "Acute heart failure syndromes", J Am Coll Cardiol, 53, pp.557~573 (2009)[DOI]
2. Adams KF Jr, "Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)", Am Heart J, 149, pp.209~216 (2005)[DOI]
3. Go AS, "Heart disease and stroke statistics: 2013 update. A report from the American Heart Association", Circulation, 127, pp.e6~e245 (2013)[DOI]
4. Fang J, "Heart failure-related hospitalization in the U.S., 1979 to 2004", J Am Coll Cardiol, 52, pp.428~434 (2008)[DOI]
5. Cotter G, "The hemodynamic and neurohormonal effects of low doses of tezosentan (an endothelin A", B receptor antagonist) in patients with acute heart failure, 2004, pp.6, 601~609
6. Giamouzis G, "Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial", J Card Fail, 16, pp.922~930 (2010)[DOI]
7. Konstam MA, "Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial", JAMA, 297, pp.1319~1331 (2007)[DOI]
8. Massie BM, "Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure", N Engl J Med, 363, pp.1419~1428 (2010)[DOI]
9. McMurray JJ, "Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials", JAMA, 298, pp.2009~2019 (2007)[DOI]
10. O'Connor CM, "Effect of nesiritide in patients with acute decompensated heart failure", N Engl J Med, 365, pp.32~43 (2011)[DOI]
11. McMurray JJ, "ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC", Eur J Heart Fail, 14, pp.803~869 (2012)[DOI]
12. Yancy CW, "2013 ACCF", AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation, J Am Coll Cardiol, pp.2013, 62[DOI]
13. Kociol RD, "Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure", Circ Heart Fail, 6, pp.240~245 (2013)[DOI]
14. Mentz RJ, "Pathophysiology and clinical evaluation of acute heart failure", Nat Rev Cardiol, 13, pp.28~35 (2016)[DOI]
15. Zile MR, "Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures", Circulation, 118, pp.1433~1441 (2008)[DOI]
16. Mullens W, "Renal sodium avidity in heart failure: from pathophysiology to treatment strategies", Eur Heart J, 38, pp.1872~1882 (2017)[DOI]
17. Nijst P, "The pathophysiological role of interstitial sodium in heart failure", J Am Coll Cardiol, 65, pp.378~388 (2015)[DOI]
18. Gelman S, "Venous function and central venous pressure: a physiologic story", Anesthesiology, 108, pp.735~748 (2008)[DOI]
19. Greenway CV, "Role of splanchnic venous system in overall cardiovascular homeostasis", Fed Proc, 42, pp.1678~1684 (1983)
20. Miller WL, "Understanding the heterogeneity in volume overload and fluid distribution in decompensated heart failure is key to optimal volume management: role for blood volume quantitation", JACC Heart Fail, 2, pp.298~305 (2014)[DOI]
21. Chaudhry SI, "Patterns of weight change preceding hospitalization for heart failure", Circulation, 116, pp.1549~1554 (2007)[DOI]
22. Verbrugge FH, "Abdominal contributions to cardiorenal dysfunction in congestive heart failure", J Am Coll Cardiol, 62, pp.485~495 (2013)[DOI]
23. Androne AS, "Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes", Am J Cardiol, 93, pp.1254~1259 (2004)[DOI]
24. Greenway CV, "Capacitance effects and blood reservoir function in the splanchnic vascular bed during non-hypotensive haemorrhage and blood volume expansion in anaesthetized cats", J Physiol, 237, pp.279~294 (1974)[DOI]
25. Fallick C, "Sympathetically mediated changes in capacitance: redistribution of the venous reservoir as a cause of decompensation", Circ Heart Fail, 4, pp.669~675 (2011)[DOI]
26. Davis KL, "Effects of myocardial edema on the development of myocardial interstitial fibrosis", Microcirculation, 7, pp.269~280 (2000)[DOI]
27. Desai KV, "Mechanics of the left ventricular myocardial interstitium: effects of acute and chronic myocardial edema", Am J Physiol Heart Circ Physiol, 294, pp.H2428~H2434 (2008)[DOI]
28. Davis KL, "Myocardial edema, left ventricular function, and pulmonary hypertension", J Appl Physiol (1985), 78, pp.132~137 (1995)[DOI]
29. Mullens W, "Importance of venous congestion for worsening of renal function in advanced decompensated heart failure", J Am Coll Cardiol, 53, pp.589~596 (2009)[DOI]
30. Damman K, "Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease", J Am Coll Cardiol, 53, pp.582~588 (2009)[DOI]
31. Nijst P, "Intrarenal flow alterations during transition from euvolemia to intravascular volume expansion in heart failure patients", JACC Heart Fail, 5, pp.672~681 (2017)[DOI]
32. Adamson PB, "Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device", Circulation, 110, pp.2389~2394 (2004)[DOI]
33. Mullens W, "Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function?", J Am Coll Cardiol, 51, pp.300~306 (2008)[DOI]
34. Colombo PC, "Venous congestion, endothelial and neurohormonal activation in acute decompensated heart failure: cause or effect?", Curr Heart Fail Rep, 12, pp.215~222 (2015)[DOI]
35. Binanay C, "Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial", JAMA, 294, pp.1625~1633 (2005)[DOI]
36. Drazner MH, "Relationship between right and left-sided filling pressures in 1000 patients with advanced heart failure", J Heart Lung Transplant, 18, pp.1126~1132 (1999)[DOI]
37. Capomolla S, "Echo-Doppler and clinical evaluations to define hemodynamic profile in patients with chronic heart failure: accuracy and influence on therapeutic management", Eur J Heart Fail, 7, pp.624~630 (2005)[DOI]
38. Rohde LE, "A hemodynamically oriented echocardiography-based strategy in the treatment of congestive heart failure", J Card Fail, 13, pp.618~625 (2007)[DOI]
39. Francis GS, "A test in context: critical evaluation of natriuretic peptide testing in heart failure", J Am Coll Cardiol, 67, pp.330~337 (2016)
40. Verbrugge FH, "New insights into combinational drug therapy to manage congestion in heart failure", Curr Heart Fail Rep, 11, pp.1~9 (2014)[DOI]
41. Guyton AC, "Interstitial fluid pressure. IV. Its effect on fluid movement through the capillary wall", Circ Res, 19, pp.1022~1030 (1966)[DOI]
42. ter Maaten JM, "Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy", Nat Rev Cardiol, 12, pp.184~192 (2015)[DOI]
43. Fonarow GC, "Overview of acutely decompensated congestive heart failure (ADHF): a report from the ADHERE registry", Heart Fail Rev, 9, pp.179~185 (2004)
44. Felker GM, "Diuretic strategies in patients with acute decompensated heart failure", N Engl J Med, 364, pp.797~805 (2011)[DOI]
45. Matsue Y, "Time-to-furosemide treatment and mortality in patients hospitalized with acute heart failure", J Am Coll Cardiol, 69, pp.3042~3051 (2017)[DOI]
46. Martens P, "Changes in loop diuretic dose and outcome after cardiac resynchronization therapy in patients with heart failure and reduced left ventricular ejection fractions", Am J Cardiol, 120, pp.267~273 (2017)[DOI]
47. Jentzer JC, "Combination of loop diuretics with thiazide-type diuretics in heart failure", J Am Coll Cardiol, 56, pp.1527~1534 (2010)[DOI]
48. Kim GH, "Long-term adaptation of renal ion transporters to chronic diuretic treatment", Am J Nephrol, 24, pp.595~605 (2004)[DOI]
49. Verbrugge FH, "Hyponatremia in acute decompensated heart failure: depletion versus dilution", J Am Coll Cardiol, 65, pp.480~492 (2015)[DOI]
50. Martens P, "Current approach to decongestive therapy in acute heart failure", Curr Heart Fail Rep, 12, pp.367~378 (2015)[DOI]
51. Butler J, "Efficacy and safety of spironolactone in acute heart failure: the ATHENA-HF randomized clinical trial", JAMA Cardiol, 2, pp.950~958 (2017)[DOI]
52. Verbrugge FH, "Determinants and impact of the natriuretic response to diuretic therapy in heart failure with reduced ejection fraction and volume overload", Acta Cardiol, 70, pp.265~273 (2015)[DOI]
53. Martens P, "Promise of SGLT2 inhibitors in heart failure: diabetes and beyond", Curr Treat Options Cardiovasc Med, 19, pp.23~ (2017)[DOI]
54. Neal B, "Canagliflozin and cardiovascular and renal events in type 2 diabetes", N Engl J Med, 377, pp.644~657 (2017)[DOI]
55. Zinman B, "Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes", N Engl J Med, 373, pp.2117~2128 (2015)[DOI]
56. Costanzo MR, "Extracorporeal ultrafiltration for fluid overload in heart failure: current status and prospects for further research", J Am Coll Cardiol, 69, pp.2428~2445 (2017)
57. Lala A, "Relief and recurrence of congestion during and after hospitalization for acute heart failure: insights from Diuretic Optimization Strategy Evaluation in Acute decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in acute decompensated Heart Failure (CARESS-HF)", Circ Heart Fail, 8, pp.741~748 (2015)[DOI]
58. Costanzo MR, "Interventions linked to decreased heart failure hospitalizations during ambulatory pulmonary artery pressure monitoring", JACC Heart Fail, 4, pp.333~344 (2016)[DOI]
59. Testani JM, "Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival", Circulation, 122, pp.265~272 (2010)[DOI]
60. Greene SJ, "Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial", Eur J Heart Fail, 15, pp.1401~1411 (2013)[DOI]
61. Testani JM, "Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: importance of sustained decongestion", J Am Coll Cardiol, 62, pp.516~524 (2013)[DOI]
62. van der Meer P, "The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure", J Am Coll Cardiol, 61, pp.1973~1981 (2013)[DOI]
63. Katz SD, "In search of euvolemia in heart failure", JACC Heart Fail, 2, pp.306~307 (2014)[DOI]
64. Ponikowski P, "2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure", Kardiol Pol, 74, pp.1037~1147 (2016)[DOI]
65. Mullens W, "Sodium nitroprusside for advanced low-output heart failure", J Am Coll Cardiol, 52, pp.200~207 (2008)[DOI]
66. "On bedresting in heart failure", Lancet, 336, pp.975~976 (1990)[DOI]
67. Lucas C, "Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure", Am Heart J, 140, pp.840~847 (2000)[DOI]
68. Morley D, "Assessing risk by hemodynamic profile in patients awaiting cardiac transplantation", Am J Cardiol, 73, pp.379~383 (1994)[DOI]
69. Singh A, "Agents with vasodilator properties in acute heart failure", Eur Heart J, 38, pp.317~325 (2017)[DOI]
70. Packer M, "Effect of ularitide on cardiovascular mortality in acute heart failure", N Engl J Med, 376, pp.1956~1964 (2017)[DOI]
71. Verbrugge FH, "Response and tolerance to oral vasodilator up-titration after intravenous vasodilator therapy in advanced decompensated heart failure", Eur J Heart Fail, 17, pp.956~963 (2015)[DOI]
72. Stevenson LW, "Chronic ambulatory intracardiac pressures and future heart failure events", Circ Heart Fail, 3, pp.580~587 (2010)[DOI]
73. Gheorghiade M, "Rehospitalization for heart failure: problems and perspectives", J Am Coll Cardiol, 61, pp.391~403 (2013)[DOI]
74. Fonarow GC, "Association between performance measures and clinical outcomes for patients hospitalized with heart failure", JAMA, 297, pp.61~70 (2007)[DOI]
75. Kula AJ, "Influence of titration of neurohormonal antagonists and blood pressure reduction on renal function and decongestion in decompensated heart failure", Circ Heart Fail, 9, pp.e002333~ (2016)[DOI]

관련 논문AI추천